Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-730-0 | CAS number: 12627-14-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral (OECD 423), rat: LD50 cut-off: 2500 mg/kg bw (limit test)
Inhalation: due to physicochemical properties inhalation is unlikely to occur
Dermal: negligible dermal absorption through the skin
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 500 mg/kg bw
Additional information
Oral
The acute oral toxicity of silicic acid, lithium salt (Molar Ratio SiO2/Li2O: 4.8) was determined in a GLP-Guideline study according to OECD 423 (Colas, 2010). The test substance was administered to 6 female rats at a dose of 2000 mg/kg bw. The death of two animals was noted on day 1 and day 2 post-dose, respectively. The mortalities were preceded by a decrease in spontaneous activity (2/2), and in body temperature (2/2), increased lachrymation (1/2), bradypnea (2/2), tremors (1/2), piloerection (1/2) and absence of righting reflex (1/2). Macroscopical examinations revealed a thinning of the corpus associated with red spots in both animals and a thinning of the forestomach in one of the two dead animals. The observed effects may be a consequence to the alkalinity of the test substance. This assumption is confirmed by acute oral toxicity studies with silicic acid, sodium salt or sodium metasilicate, in which the toxicity the observed toxicological symptoms are indicative effects due to alkalinity (CEES, 2008).
In the survival animals, similar observations including a decrease in spontaneous activity (4/4), and in body temperature (1/4), increased lachrymation (1/4), bradypnea (2/4), piloerection (2/4) and absence of righting reflex (2/4) were made on the first day of the study. All animals recovered to a normal behaviour at 24 hours post-dose. No treatment-related changes were noted in the four surviving rats at necropsy at the end of the study.
In conclusion, the oral LD50 cut-off value for silicic acid, lithium salt is 2500 mg/kg bw in the rat according to the acute toxic class method described in the OECD guideline 423 since one animal each died in two separate steps.
Inhalation
An acute inhalation limit test with the technical product AgSil™ 25 Potassium Silicate Solution (active ingredient: 30%) no deaths occurred after inhalation of 2 mg/L (MMAD 2.7µm) for 4 hours (Durando, 2004). Hunched posture and hypoactivity were noted during in-chamber animal observations. These clinical signs were reversible, after removal from the exposure chambers all rats appeared active and healthy over the 14-day observation period. Thus, the LC50 of the test substance is considered to be greater than 2.06 mg/L in rats.
However, silicic acid, lithium salt contains ca. 85.5% particles with a particle size larger than 149 μm, and ca. 14.7% particles with a particle size between 18 μm and 149 µm. Very few particles are smaller than 18 μm (IUCLID section 4.5: Paulus, 2010). Therefore, the test substance is rarely inhalable (particles < 100 µm) and even less respirable (particles < 4 µm). If particles are inhaled they will remain in the upper airways and/or will be either be coughed out or swallowed, with few or no particles reaching the pulmonary alveoli. Toxic effects after swallowing is sufficiently covered by the available acute oral toxicity study.
For an inhalation assay grinding to a fine and respirable powder would be required, representing a test substance, which is not existing under real life conditions.
The vapour pressure of silicic acid, lithium salt will be immeasurably small, which also indicates a low potential for exposure via inhalation. The vapour pressures for solid e.g. sodium silicates were extremely low (0.016 hPa at 1172 °C (MR 3.0); 0.0031 hPa at 1165 °C (MR 2.0)) and it is not expected that these for silicic acid, lithium salt vary significantly from those determined.
In addition for workers, the implemented risk management measures ensure that the potential for acute toxicity via the inhalation route is estimated to be minimal.
Therefore, during normal handling and use of silicic acid, lithium salt, it can be assumed that no acute toxic effects due to inhalation of the test substance are likely to occur.
Dermal
No reliable QSAR estimations for the dermal absorption rate can be provided for silicic acid, lithium salt due to the inorganic character of the test substance. However, Dermwin v2.01 predicts a permeability constant of 5.78E-07 cm/h based on an estimated Log Pow of -4.46. Although this value is outside the estimation domain of the QSAR tool, the dermal absorption rate for silicic acid, lithium salt can be regarded as very low.
The assumption, that after contact with silicic acid, lithium salt, the bioavailability of the test substance is very low, was confirmed in an acute dermal limit test with AgSil™ 25 Potassium Silicate Solution (active ingredient: 30%). There was a complete absence of mortalities after application of 5000 mg potassium silicate solution/kg bw to the skin of ten rats for 24 hours (Durando, 2004). In five animals erythema and alopecia was noted between day 1 and 8. No other effects were noted. Under the conditions of the test, the dermal LD50 for potassium silicate solution is greater than 5000 mg/kg bw.
In conclusion, the acute oral toxicity study, which resulted in an LD50 > 2000 mg/kg bw, is considered as worst case scenario in regard to systemic effects after short-term exposure to silicic acid, lithium salt.
References
CEES, Centre Européen d’Etudes des Silicates: Soluble Silicates, Chemical, toxicological, ecological and legal aspects of production, transport, handling and application, last update: June 2008, http://www.cees-silicates.org/recentpublicationscees.html
Justification for classification or non-classification
The available data on acute toxicity of the test substance do not meet the criteria for classification according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.